Hudson Bay Capital Management
BNR

Hudson Bay Capital Management’s Burning Rock Biotech BNR Stock Holding History

Hudson Bay Capital Management’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,349
Closed -$1.24M – 1337
2022
Q1 		$1.24M Sell
13,349
-16,757
-56% -$1.46M 0.02% 793
2021
Q4 		$2.87M Hold
30,106
– – 0.03% 573
2021
Q3 		$5.38M Hold
30,106
– – 0.07% 305
2021
Q2 		$8.87M Hold
30,106
– – 0.11% 166
2021
Q1 		$8.11M Sell
30,106
-34,263
-53% -$10.4M 0.1% 155
2020
Q4 		$14.9M Buy
64,369
+5,500
+9% +$1.48M 0.16% 79
2020
Q3 		$14.8M Buy
58,869
+5,138
+10% +$1.22M 0.22% 78
2020
Q2 		$14.5M Buy
+53,731
New +$14.7M 0.25% 63

Other funds holding BNR

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Hudson Bay Capital Management's BNR Position: Q2 2022 in Review

Hudson Bay Capital Management sold out of Burning Rock Biotech (BNR) in Q2 2022, closing a stake of 13,349 shares — an estimated $1.24M sold.

Hudson Bay Capital Management first reported a position in BNR in Q2 2020 and held it in 8 quarters. The position peaked at $14.9M in Q4 2020. 50 funds tracked by Wall St. Rank hold BNR as of Q2 2022.

  • Hudson Bay Capital Management reported no remaining Burning Rock Biotech position as of Q2 2022 after selling out during the quarter.
  • Hudson Bay Capital Management sold 13,349 Burning Rock Biotech shares in Q2 2022, an estimated $1.24M.
  • Hudson Bay Capital Management first reported a position in Burning Rock Biotech in Q2 2020 and held it in 8 quarters.
  • Hudson Bay Capital Management's Burning Rock Biotech position peaked at $14.9M in Q4 2020.
  • 50 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2022.

Based on Hudson Bay Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.